Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DELIRE-ICU: Melatonin vs Placebo in the Treatment of Delirium in the ICU
NCT05713877Phase 2Recruiting
- Start
- Feb 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in delirium. Started Feb 2023; status: recruiting.
02
Drugs
melatonin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT05713877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05713877.